Clinical Trial Update: Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

View source ↗

Summary

A prospective cohort trial is recruiting germline BRCA1/BRCA2 variant carriers to study cancer risk in ovarian, fallopian tube, and primary peritoneal carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: BRCA1 and/or BRCA2 Variant Carriers, Ovarian Carcinoma | Status: RECRUITING